Analyze Diet
Journal of veterinary internal medicine2009; 23(5); 1103-1107; doi: 10.1111/j.1939-1676.2009.0369.x

Effect of transvenous electrical cardioversion on plasma cardiac troponin I concentrations in horses with atrial fibrillation.

Abstract: Whether electrical cardioversion of cardiac arrhythmias results in cardiomyocyte damage is unknown. Objective: To describe effect of transvenous electrical cardioversion (TVEC) on plasma cardiac troponin I (cTnI) concentration in horses. Methods: All horses presented to the Cornell University Hospital for Animals for cardioversion of atrial fibrillation between May 2006 and October 2008 were eligible for inclusion in the study. Owners of 14 horses elected for TVEC and each horse was then enrolled (16 procedures). Methods: Prospective observational study measuring concentrations of plasma cTnI before and after TVEC. Results: Median cTnI concentration increased from 0.045 ng/mL at baseline (range 0.0-0.20 ng/mL) to 0.11 ng/mL after TVEC (range 0.0-3.73 ng/mL) (P= .036). This increase was not associated with the number of shocks delivered, maximal energy delivered, cumulative energy delivered, chronicity of atrial fibrillation before cardioversion, or positioning of the pulmonary artery catheter. Conclusions: The increase in cTnI is unlikely to be clinically important. The increase might be correlated with persistent atrial dysfunction after TVEC, suggesting that a longer convalescent period after the procedure could be warranted.
Publication Date: 2009-08-11 PubMed ID: 19678887DOI: 10.1111/j.1939-1676.2009.0369.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper investigates the impact of transvenous electrical cardioversion (TVEC), a procedure for correcting heart arrhythmias, on plasma cardiac troponin I concentrations in horses and checks whether this process inflicts damage to heart cells. It finds a statistically significant increase in cTnI, a marker for heart cell damage, post-procedure but suggests this increase is probably not clinically significant.

Research Objective

  • The main purpose of the research was to assess the effects of TVEC—a procedure used to restore heart’s rhythm—on the levels of plasma cTnI in horses. cTnI is a biomarker which, at high concentrations, signals cardiac muscle injury or damage.

Methods

  • The study was an observational one, conducted with data collected from a total of 14 horses brought to the Cornell University Hospital for Animals for cardioversion of atrial fibrillation, a type of heart rhythm disorder.
  • The study period ran from May 2006 to October 2008.
  • In total, there were 16 procedures conducted on the 14 horses.
  • The plasma cTnI concentrations in the horses were monitored both before and after they underwent TVEC.

Results

  • The median cTnI concentration recorded in these horses rose from 0.045 ng/mL before the procedure to 0.11 ng/mL after the procedure. This increase was found to be statistically significant (P=.036).
  • The study did not find a relationship between the increase in cTnI levels and factors like the number of shocks delivered, the maximum energy administered, the total energy administered, how long the horse had had atrial fibrillation before the procedure, or how the catheter was placed in the pulmonary artery during the procedure.

Conclusions

  • Although the study found a significant increase in cTnI levels following TVEC, it posited that this increase is unlikely to be clinically important, meaning it probably does not indicate a harmful degree of cardiomyocyte (cardiac muscle cell) damage.
  • The paper suggested that the rise in cTnI might have a correlation with a continued dysfunction of the atria following TVEC. Consequently, it recommended a possibly longer recovery period for horses after the procedure.

Cite This Article

APA
Jesty SA, Kraus MS, Gelzer AR, Rishniw M, Moise NS. (2009). Effect of transvenous electrical cardioversion on plasma cardiac troponin I concentrations in horses with atrial fibrillation. J Vet Intern Med, 23(5), 1103-1107. https://doi.org/10.1111/j.1939-1676.2009.0369.x

Publication

ISSN: 0891-6640
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 23
Issue: 5
Pages: 1103-1107

Researcher Affiliations

Jesty, S A
  • Department of Clinical Sciences, Cornell University Hospital for Animals, P.O. Box 34, Ithaca, NY 14850, USA. saj2@cornell.edu
Kraus, M S
    Gelzer, A R
      Rishniw, M
        Moise, N S

          MeSH Terms

          • Animals
          • Atrial Fibrillation / blood
          • Atrial Fibrillation / therapy
          • Atrial Fibrillation / veterinary
          • Electric Countershock / adverse effects
          • Electric Countershock / methods
          • Electric Countershock / veterinary
          • Female
          • Horse Diseases / blood
          • Horse Diseases / therapy
          • Horses
          • Male
          • Prospective Studies
          • Statistics, Nonparametric
          • Troponin I / blood

          Citations

          This article has been cited 3 times.
          1. Foreman JH, Tennent-Brown BS, Oyama MA, Sisson DD. Plasma Cardiac Troponin-I Concentration in Normal Horses and in Horses with Cardiac Abnormalities. Animals (Basel) 2025 Jan 3;15(1).
            doi: 10.3390/ani15010092pubmed: 39795035google scholar: lookup
          2. Vernemmen I, Buschmann E, Van Steenkiste G, Demeyere M, Verhaeghe LM, De Somer F, Devreese KMJ, Schauvliege S, Decloedt A, van Loon G. Intracardiac ultrasound-guided transseptal puncture in horses: Outcome, follow-up, and perioperative anticoagulant treatment. J Vet Intern Med 2024 Sep-Oct;38(5):2707-2717.
            doi: 10.1111/jvim.17158pubmed: 39086137google scholar: lookup
          3. Marly-Voquer C, Schwarzwald CC, Bettschart-Wolfensberger R. The use of dexmedetomidine continuous rate infusion for horses undergoing transvenous electrical cardioversion--A case series. Can Vet J 2016 Jan;57(1):70-5.
            pubmed: 26740702